A case of gastric cancer with perforation caused by chemotherapy with docetaxel and S-1

J Nippon Med Sch. 2013;80(6):451-5. doi: 10.1272/jnms.80.451.

Abstract

We treated a patient who had gastrointestinal perforation during chemotherapy with docetaxel and S-1 which was successfully treated with percutaneous drainage. A 66-year-old man was admitted to our hospital with complaints of abdominal pain. Gastric cancer (T3N1M0) had been diagnosed 3 years earlier, and distal gastrectomy had been performed. Two years later, intrapelvic recurrence of the cancer was diagnosed. We administered docetaxel and S-1. After 3 courses of chemotherapy, he complained of abdominal pain of sudden onset. Computed tomography showed free air and limited ascites, and gastrointestinal perforation was diagnosed. We performed percutaneous drainage. The abdominal pain improved 3 days later, and he was able to eat meals 15 days after the onset of abdominal pain. He was discharged 27 days after admission. Because the patient's general condition was poor, we started providing best supportive care only. He died 10 months after the perforation was found.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Docetaxel
  • Drug Combinations
  • Fatal Outcome
  • Humans
  • Intestinal Perforation / chemically induced*
  • Intestinal Perforation / diagnostic imaging
  • Male
  • Oxonic Acid / adverse effects*
  • Oxonic Acid / therapeutic use*
  • Radiography, Abdominal
  • Stomach Neoplasms / diagnostic imaging
  • Stomach Neoplasms / drug therapy*
  • Taxoids / adverse effects*
  • Taxoids / therapeutic use*
  • Tegafur / adverse effects*
  • Tegafur / therapeutic use*
  • Tomography, X-Ray Computed

Substances

  • Drug Combinations
  • Taxoids
  • S 1 (combination)
  • Tegafur
  • Docetaxel
  • Oxonic Acid